颈动脉内膜剥脱术中生物心包补片与人工补片的短期和长期结局:一项回顾性双中心研究
该回顾性双中心研究分析了2014至2015年两家法国大学医院342例颈动脉内膜剥脱术(CEA),比较牛心包补片(BPP,168例)与人工补片(PP,174例)的结局。中位随访30个月,两组在再狭窄率、卒中、死亡及感染方面均无显著差异,肾功能衰竭是再狭窄的主要危险因素。
要点
- BPP与PP在CEA术后再狭窄、卒中、死亡及感染率上无显著差异。
- 肾功能衰竭与再狭窄风险升高相关(OR=2.69)。
- 仍需更大样本研究进一步验证两种补片的效果。
核心结论
- BPP与PP在CEA术后的卒中、死亡、出血、感染及再狭窄率相当,两种补片结局可比。
研究设计与样本
- 回顾性双中心研究,纳入2014至2015年法国蒙彼利埃和尼姆大学医院所有CEA病例,排除外翻式CEA,共342例(BPP组168例,PP组174例),中位随访30个月(IQR=24)。
主要发现
- 30天卒中率为3.22%,30天死亡率为1.86%。
- 随访结束时,>50%再狭窄率为7.31%(BPP组6.45% vs PP组8.22%,P=0.55)。
- >70%严重再狭窄率为4.65%(BPP组5.16% vs PP组4.11%,P=0.79)。
- 单因素分析显示肾功能衰竭是主要危险因素(OR=2.69)。
- 术后感染率为1.17%(BPP组0.59% vs PP组1.75%,P=0.62)。
临床怎么用
- 在CEA中,BPP与PP均可选择,短期和长期结局相当。
- 对于肾功能衰竭患者,应关注再狭窄风险。
局限性
- 回顾性研究设计可能引入选择偏倚。
- 样本量有限,需更大样本研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Currently, there are various types of patches available on the market for carotid endarterectomy (CEA) with enlargement angioplasty, prosthetic, and biological patches including bovine pericardial patches. Despite the increasing use of these biological patches, there are little data in the literature comparing the results of these 2 types of patch. The purpose of this study is to compare the short- and long-term results of bovine pericardium patches (BPPs) with prosthetic patches (PPs) in carotid thromboendarterectomy. METHODS: This study presents a retrospective analysis of all CEAs performed at Montpellier and Nîmes University Hospitals (France) in 2014 and 2015. Patients who underwent eversion were excluded. Preoperative, peroperative, and postoperative clinical and Doppler ultrasound results were collected and analyzed. The primary end point was the comparison of the restenosis rate between the BPP and the PP group. Secondary end points were the analysis of restenosis risk factors (type of patch, gender, renal failure, smoking, diabetes, arterial hypertension, dyslipidemia, and redo surgery were analyzed); the comparison of morbidity-mortality and infection between the BPP and the PP group and the comparison of morbidity-mortality between symptomatic and asymptomatic stenosis. RESULTS: In total, 342 CEAs were performed: 168 (49%) with BPP and 174 (51%) with PP. Median follow-up was 30 months (interquartile range = 24). The stroke rate at day 30 was 3.22% and mortality at day 30 was 1.86%. There was no significant difference between groups concerning anyone of the variables of interest. At the end of follow-up, the restenosis rate >50% was 7.31% (6.45% for the BPP group vs. 8.22% for the PP group, P = 0.55). The severe restenosis rate (>70%) was 4.65% (5.16% for the BPP group vs. 4.11% for the PP group, P = 0.79). The univariate analysis identified renal failure (odds ratio = 2.69) as the main risk factor. The postoperative infection rate was 1.17% (0.59% for the BPP group vs. 1.75% for the PP group, P = 0.62). CONCLUSIONS: The rates of stroke and postoperative death, bleeding, infection, and restenosis are comparable between BPPs and PPs in our study. The use of prosthetic or biological patches seems to deliver comparable outcomes. Further studies on larger samples are required.
引用
- Léonore FT, Elsa F, David PC, et al. Short- and Long-Term Outcomes Following Biological Pericardium Patches Versus Prosthetic Patches for Carotid Endarterectomy: A Retrospective Bicentric Study. Ann Vasc Surg. 2020. PMID: 32339685. doi:10.1016/j.avsg.2020.04.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。